Thermo Fisher Scientific has settled a lawsuit brought by the estate of Henrietta Lacks, whose cells have been used extensively in biomedical research since her death in 1951 at the age of 31. Terms were not disclosed but attorneys on both sides said that they were satisfied.

French-based CDMO Novasep has announced two sales. Henagen, its Belgium-based viral vectors operation, has been sold to Thermo Fisher Scientific for about €725 million, while, in a much smaller deal, it also intends to sell its chromatography equipment division to Sartorius Stedim Biotech.